Abstract
The identification of efficacious psychological and psychiatric therapies is arguably one of the most significant achievements in the pediatric anxiety disorders field. Controlled trials have supported the usefulness of psychological and pharmacological monotherapies for pediatric obsessive–compulsive disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, specific phobia, posttraumatic stress disorder, and separation anxiety disorder (Compton et al., 2004; Feeney, Foa, Treadwell, & March, 2004; In-Albon & Schneider, 2007; Reinblatt & Riddle, 2007; Seidel & Walkup, 2006; Watson & Rees, 2008). Clinical practice guidelines, developed from a synthesis of research evidence and expert opinion, have recommended cognitive-behavioral therapy (CBT) as the first line psychotherapy and treatment of choice (American Academy of Child and Adolescent Psychiatry (AACAP), 2007; Canadian Psychiatric Association (CPA), 2006). The selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacological agents for pediatric anxiety disorders. Second or third-line pharmacotherapy alternatives include noradrenergic antidepressants (tricyclic antidepressants (TCAs), venlafaxine), benzodiazepines, and buspirone.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
In the POTS (2004) trial, there were 154 youth screened. Of these, 112 were randomized to treatment, 31 were deemed ineligible, 10 were not interested in participating, and 1 was asymptomatic at baseline. Of those contactable and able to participate in treatment (n = 143), 78% (n = 122 of 143) were randomized and 22% (n = 31 of 143) were deemed ineligible. In the CAMS (2008) trial, 3,066 youth were screened. Of these, 488 were randomized to treatment, 1,223 were deemed ineligible, 817 were not interested in participating, 462 were not contactable, and 73 could not participate for other reasons, and 3 were asymptomatic at baseline. Of those who were contactable and able to participate in treatment (n = 1711), 29% (n = 488 of 1711) were deemed eligible and were randomized to treatment, and 71% (n = 1223 of 1711) were deemed ineligible and were not included in the study.
References
Albano, A. M., & Kendall, P. C. (2002). Cognitive behavioural therapy for children and adolescents with anxiety disorders: Clinical research advances. International Review of Psychiatry, 14, 129–134.
Alessi, N., & Bos, T. (1991). Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder. American Journal of Psychiatry, 148, 1605–1606.
American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 27S–45S.
American Academy of Child and Adolescent Psychiatry. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 267–283.
American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3 rd ed., revised). Washington, DC: APA.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: APA.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: APA.
Ballenger, J. C., Carek, D. J., Steele, J. J., & Cornish-McTighe, D. (1989). Three cases of panic disorder with agoraphobia in children. American Journal of Psychiatry, 146, 922–924.
Barlow, D. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). New York: Guilford.
Barrett, P. M. (1998). Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders. Journal of Clinical Child Psychology, 27, 459–468.
Barrett, P. M., Dadds, M. R., & Rapee, R. M. (1996). Family treatment of childhood anxiety: A controlled trial. Journal of Consulting and Clinical Psychology, 64, 333–342.
Başoğlu, M., Marks, I. M., Killiç, C., Brewin, C. R., & Swinson, R. P. (1994). Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652–659.
Beck, A. T., Emery, G., & Greenberg, R. (1985). Anxiety disorders and phobias: A cognitive perspective. New York: Basic Books.
Bernstein, G. A., Borchardt, C. M., & Perwien, A. R. (1996). Anxiety disorders in children and adolescents: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1110–1119.
Bernstein, G. A., Borchardt, C. M., Perwien, A. R., Crosby, R. D., Kushner, M. G., Thuras, P. D., et al. (2000). Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 276–283.
Bernstein, G. A., Crosby, R. D., Perwien, A. R., & Borchardt, C. M. (1996). Anxiety Rating for Children – Revised: Reliability and validity. Journal of Anxiety Disorders, 10, 97–114.
Bernstein, G. A., Garfinkel, B. D., & Borchardt, C. M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 773–781.
Bernstein, G. A., Hektner, J. M., Borchardt, C. M., & McMillan, M. H. (2001). Treatment of school refusal: One-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 206–213.
Canadian Psychiatric Association. (2006). Clinical practice guidelines: Management of anxiety disorders. Canadian Journal of Psychiatry, 51(suppl. 2), S1–S93.
Cartwright-Hatton, S., Roberts, C., Chitsabesan, P., Fothergill, C., & Harrington, R. (2004). Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. British Journal of Clinical Psychology, 43, 421–436.
Casey, L. M., Newcombe, P. A., & Oei, T. P. S. (2005). Cognitive mediation of panic severity: The role of catastrophic misinterpretation of bodily sensations and panic self-efficacy. Cognitive Therapy and Research, 29, 187–200.
Cobham, V. E., Dadds, M. R., & Spence, S. H. (1998). The role of parental anxiety in the treatment of childhood anxiety. Journal of Consulting and Clinical Psychology, 66, 893–905.
Cohen, J. A., Mannarino, A. P., Perel, J. M., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 811–819.
Compton, S. C., Kratovchil, C. J., & March, J. S. (2007). Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review. Pediatric Annals, 36, 586–598.
Compton, S. C., March, J. S., Brent, D., Albano, A. M., Weersing, R., & Curry, J. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 930–959.
Craske, M. G., Roy-Byrne, P., Stein, M. B., Donald-Sherbourne, C., Bystritsky, A., Katon, W., et al. (2002). Treating panic disorder in primary care: A collaborative care intervention. General Hospital Psychiatry, 24, 148–155.
de Haan, E., Hoogduin, K. A. L., Buitelaar, J. K., & Keijsers, G. P. J. (1998). Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1022–1029.
Echeburua, E., De Corral, P., Garcia Bajos, E. G., & Borda, M. (1993). Interactions between self-exposure and alprazolam in the treatment of agoraphobia without current panic: An exploratory study. Behavioural and Cognitive Psychotherapy, 21, 219–238.
Eisen, A. R., Raleigh, H., & Neuhoff, C. C. (2008). The unique impact of parent training for separation anxiety disorder in children. Behavior Therapy, 39, 195–206.
Emslie, G., Kratochvil, C., Vitiello, B., Silva, S., Mayes, T., McNulty, S., et al. (2006). Treatment for Adolescents with Depression Study (TADS): Safety results. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1440–1455.
Feeney, N. C., Foa, E. B., Treadwell, K. R. H., & March, J. (2004). Posttraumatic stress disorder in youth: A critical review of the cognitive and behavioral treatment outcome literature. Professional Psychology: Research and Practice, 35, 466–476.
Foa, E. B., Franklin, M. E., & Moser, J. (2002). Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination? Biological Psychiatry, 52, 987–997.
Gaudiano, B. A., & Herbert, J. D. (2007). Self-efficacy for social situations in adolescents with generalized social anxiety disorder. Behavioral and Cognitive Psychotherapy, 35, 209–223.
Gittelman-Klein, R., & Klein, D. F. (1973). School phobia: Diagnostic considerations in the light of imipramine effects. Journal of Nervous and Mental Disease, 156, 199–215.
Golombok, S., Stavrou, A., Bonn, J., Mogg, K., Critchlow, S., & Rust, J. (1991). Effects of diazepam on anxiety-related cognition. Cognitive Therapy and Research, 15, 459–467.
Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 372–376.
Guy, W. (1976). ECDEU assessment manual for psychopharmacology. Rockville, MD: Department of Health, Education, and Welfare.
Hafner, J., & Marks, I. (1976). Exposure in vivo of agoraphobics: Contributions of diazepam, group exposure, and anxiety evocation. Psychological Medicine, 6, 71–88.
Hansen, B., Vogel, P. A., Stiles, T. C., & Götestam, K. G. (2007). Influence of comorbid generalized anxiety disorder, panic disorder, and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder. Cognitive Behaviour Therapy, 36, 145–155.
In-Albon, T., & Schneider, S. (2007). Psychotherapy of childhood anxiety disorders: A meta-analysis. Psychotherapy and Psychosomatics, 76, 15–24.
Insel, T. R., Hoover, C., & Murphy, D. L. (1983). Parents of patients with obsessive-compulsive disorder. Psychological Medicine, 13, 807–811.
Jensen, H. H., Hutchings, B., & Poulsen, J. C. (1989). Conditioned emotional responding under diazepam: A psychophysiological study of state dependent learning. Psychopharmacology, 98, 392–397.
Johnston, D., & Gath, D. (1973). Arousal levels and attribution effects in diazepam-assisted flooding. British Journal of Psychiatry, 123, 463–466.
Joormann, J., Kosfelder, J., & Schulte, D. (2005). The impact of comorbidity of depression on the course of anxiety treatments. Cognitive Therapy and Research, 29, 569–591.
Kampman, M., Keijers, G. P. J., Hoogduin, C. A. L., & Hendriks, G. (2008). Outcome prediction of cognitive behaviour therapy for panic disorder: Initial symptom severity is predictive for treatment outcome, comorbid anxiety or depressive disorder, Cluster C personality disorders and initial motivation are not. Behavioural and Cognitive Psychotherapy, 36, 99–112.
Kendall, P. C., Brady, E. U., & Verduin, T. L. (2001). Comorbidity in child anxiety disorders and treatment outcome. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 787–794.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., & Warman, M. (1997). Therapy for youths with anxiety disorders: A second randomized clinical trial. Journal of Consulting and Clinical Psychology, 65, 366–380.
Kendall, P. C., & Hedtke, K. A. (2006a). Cognitive-behavioral therapy for anxious children: Therapist manual (3rd ed.). Ardmore: Workbook.
Kendall, P. C., & Hedtke, K. A. (2006b). Coping cat workbook (2nd ed.). Ardmore: Workbook.
Knight, R. G., & Longmore, B. E. (1994). Clinical neuropsychology of alcoholism. Hillsdale, NJ: Lawrence Erlbaum.
Labellarte, M. J., Ginsburg, G. S., Walkup, J. T., & Riddle, M. A. (1999). The treatment of anxiety disorders in children. Biological Psychiatry, 46, 1567–1578.
Last, C. G., Hansen, C., & Franko, N. (1998). Cognitive-behavioral treatment of school-refusing children. Journal of the American Academy of Child and Adolescent Psychiatry, 37(4), 404–411.
Leonard, H. L., Topol, D., Bukstein, O., Hindmarsh, D., Allen, A. J., & Swedo, S. E. (1994). Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 792–794.
Lesser, I. M., Rubin, R. T., Pecknold, J. C., Rifkin, A., Swinson, R. P., Lydiard, R. B., et al. (1988). Secondary depression in panic disorder and agoraphobia: I. Frequency, severity, and response to treatment. Archives of General Psychiatry, 45, 437–443.
March, J., & Mulle, K. (1998). OCD in children and adolescents: A cognitive-behavioral treatment manual. New York: Guilford.
March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., et al. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA, 292, 807–820.
Marks, I. M., Swinson, R. P., Başoğlu, M., Kuch, K., Noshirvani, H., O’Sullivan, G., et al. (1993). Alprazolam and exposure alone and in combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776–787.
Marks, I. M., Viswanathan, R., Lipsedge, M. S., & Gardner, R. (1972). Enhanced relief of phobias by flooding during waning diazepam effect. British Journal of Psychiatry, 121, 493–505.
Marom, S., Gilboa-Schechtman, E., Aderka, I. M., Weizman, A., & Hermesh, H. (2009). Impact of depression on treatment effectiveness and gains maintenance in social phobia: A naturalistic study of cognitive behaviour group therapy. Depression and Anxiety, 26, 289–300.
Mogg, K., Baldwin, D. S., Brodrick, P., & Bradley, B. P. (2004). Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. Psychopharmacology, 176, 466–470.
Mohanty, A., & Heller, W. (2002). The neuropsychology of mood disorders: Affect, cognition and neural circuitry. In H. A. H. D’haenen, J. A. den Boer, & P. Willner (Eds.), Biological Psychiatry ((pp, Vol. 2, pp. 791–802). London: Wiley.
Morisette, S. B., Spiegel, D. A., & Barlow, D. H. (2008). Combining exposure and pharmacotherapy in the treatment of social anxiety disorder: A preliminary study of state dependent learning. Journal of Psychopathology and Behavioral Assessment, 30, 211–219.
Neziroglu, F., Yaryura-Tobias, J. A., Walz, J., & McKay, D. (2000). The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 10, 295–306.
O’Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pelissier, M. C., Todorov, C., et al. (2006). Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatrica Scandinavica, 113, 408–419.
Otto, M. W., Pollack, M. H., & Sabatino, S. A. (1996). Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment. Behavior Therapy, 27, 473–482.
Otto, M. W., Smits, J. A. J., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12, 72–86.
Pediatric OCD Treatment Study (POTS) Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. JAMA, 292, 1969–1976.
Powers, M. B., Smits, J. A. J., & Telch, M. J. (2004). Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: A placebo-controlled trial. Journal of Consulting and Clinical Psychology, 72, 448–454.
Poznanski, E. O., Freeman, L. N., & Mokros, H. B. (1985). Children’s Depression Rating Scale – Revised. Psychopharmacology Bulletin, 21, 979–989.
Rapee, R. M. (2003). The influence of comorbidity on treatment outcome for children and adolescents with anxiety disorders. Behaviour Research and Therapy, 41, 105–112.
Reinblatt, S. P., & Riddle, M. A. (2007). The pharmacological management of childhood anxiety disorders: A review. Psychopharmacology, 191, 67–86.
Research Units on Pediatric Psychopharmacology Anxiety Study Group. (2002). The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1061–1069.
Riley, W. T., McCormick, M. G. F., Simon, E. M., Stack, K., Pushkin, Y., Overstreet, M. M., et al. (1995). Effects of alprazolam dose on the induction and habituation processes during behavioural panic induction treatment. Journal of Anxiety Disorders, 9, 217–228.
Salkovskis, P. M. (1991). The importance of behaviour in the maintenance of anxiety and panic: A cognitive account. Behavioral Psychotherapy, 19, 6–19.
Sallee, F. R., & March, J. S. (2000). Neuropsychiatry of paediatric anxiety disorders. In W. K. Silverman & P. D. A. Treffers (Eds.), Anxiety disorders in children and adolescents: Research, assessment and intervention (pp. 90–125). Cambridge: Cambridge University Press.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–852.
Seidel, L., & Walkup, J. T. (2006). Selective serotonin reuptake inhibitor use in the treatment of pediatric non-obsessive-compulsive disorder anxiety disorders. Journal of Child and Adolescent Psychopharmacology, 16, 171–179.
Seligman, L. D., & Ollendick, T. H. (1998). Comorbidity of anxiety and depression in children and adolescents: An integrative review. Clinical Child and Family Psychology Review, 1, 125–144.
Simeon, J. G., Ferguson, H. B., Knott, V., Roberts, N., Gautheir, B., Dubois, C., et al. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 29–33.
Simon, N. M., Otto, M. W., Smits, J. A. J., Nicolaou, D. C., Reese, H. A., & Pollack, M. H. (2004). Changes in anxiety sensitivity with pharmacotherapy for panic disorder. Journal of Psychiatric Research, 38, 491–495.
Smits, J. A. J., Powers, M. B., Cho, Y., & Telch, M. J. (2004). Mechanism of change in cognitive-behavioral treatment of panic disorder: Evidence for the fear of fear meditational hypothesis. Journal of Consulting and Clinical Psychology, 72, 646652.
Stein, M. B., & Seedat, S. (2004). Pharmacotherapy. In T. L. Morris & J. S. March (Eds.), Anxiety disorders in children and adolescents (pp. 329–354). New York: Guilford.
Stewart, S. E., Ceranoglu, T. A., O’Hanley, T., & Gellar, D. A. (2005). Performance of clinician versus self-report measures to identify obsessive-compulsive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 15, 956–963.
Stewart, S. H., Westra, H. A., Thompson, C. E., & Conrad, B. E. (2000). Effects of naturalistic benzodiazepine use on selective attention to threat cues among anxiety disorder patients. Cognitive Therapy and Research, 24, 67–85.
Storch, E. A., Lehmkuhl, H., Geffken, G. R., Touchton, A., & Murphy, T. K. (2008). Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depression and Anxiety, 25, 172–174.
Storch, E. A., Merlo, L. J., Larson, M. J., Geffken, G. R., Lehmkuhl, H. D., Jacob, M. L., et al. (2008). Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 583–592.
Thomsen, P. H., & Mikkelson, H. U. (1999). The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder: A study of six cases. European Child and Adolescent Psychiatry, 8, 143–148.
Tsang, R., Colley, L., & Lynd, L. D. (2009). Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials. Journal of Clinical Epidemiology, 62, 609–616.
Tsao, J. C., Lewin, M. R., & Craske, M. G. (1998). The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. Journal of Anxiety Disorders, 12, 357–371.
van Balkom, A. J., van Boeijen, C. A., Boeke, A. J., van Oppen, P., Kempe, P. T., & van Dyck, R. (2008). Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depression and Anxiety, 25, 408–415.
Varley, C. K. (2000). Sudden death of a child treated with imipramine: Case study. Journal of Child and Adolescent Psychopharmacology, 10, 321–325.
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S., Sherrill, J. T., et al. (2008). Cognitive behavioural therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
Watson, H. J., & Rees, C. S. (2008). Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry, 49, 489–498.
Wells, A., Clark, D. M., Salkovskis, P., Ludgate, J., Hackmann, A., & Gelder, M. (1995). Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs. Behavior Therapy, 26, 153–161.
Westra, H. A., & Stewart, S. H. (1998). Cognitive behavioural therapy and pharmacotherapy: Compelmentary or contradictory approaches to the treatment of anxiety. Clinical Psychology Review, 18, 307–340.
Westra, H. A., Stewart, S. H., & Conrad, B. E. (2002). Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia. Journal of Anxiety Disorders, 16, 233–246.
Wilens, T., Spencer, T., Biederman, J., Wozniak, J., & Connor, D. (1995). Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 110–112.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Watson, H.J. (2011). Combined Psychological and Pharmacological Treatment of Pediatric Anxiety Disorders. In: McKay, D., Storch, E. (eds) Handbook of Child and Adolescent Anxiety Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7784-7_26
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7784-7_26
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7782-3
Online ISBN: 978-1-4419-7784-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)